These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 30071518
41. A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. Woon C, Bielinski-Bradbury A, O'Reilly K, Robinson P. BMC Nephrol; 2015 Aug 15; 16():140. PubMed ID: 26275819 [Abstract] [Full Text] [Related]
42. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). Wong ATY, Mannix C, Grantham JJ, Allman-Farinelli M, Badve SV, Boudville N, Byth K, Chan J, Coulshed S, Edwards ME, Erickson BJ, Fernando M, Foster S, Haloob I, Harris DCH, Hawley CM, Hill J, Howard K, Howell M, Jiang SH, Johnson DW, Kline TL, Kumar K, Lee VW, Lonergan M, Mai J, McCloud P, Peduto A, Rangan A, Roger SD, Sud K, Torres V, Vilayur E, Rangan GK. BMJ Open; 2018 Jan 21; 8(1):e018794. PubMed ID: 29358433 [Abstract] [Full Text] [Related]
43. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis. Raina R, Lou L, Berger B, Vogt B, Do AS, Cunningham R, Vasavada P, Herrmann K, Dell K, Simonson M. BMC Nephrol; 2016 Feb 29; 17():22. PubMed ID: 26923419 [Abstract] [Full Text] [Related]
44. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Reddy BV, Chapman AB. Pediatr Nephrol; 2017 Jan 29; 32(1):31-42. PubMed ID: 27034070 [Abstract] [Full Text] [Related]
45. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Cadnapaphornchai MA, Masoumi A, Strain JD, McFann K, Schrier RW. Clin J Am Soc Nephrol; 2011 Feb 29; 6(2):369-76. PubMed ID: 21115621 [Abstract] [Full Text] [Related]
46. Recommendations for Diagnostic and Prognostic Evaluation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) with a Focus on Imaging. Kistler AD, Andreisek G. Praxis (Bern 1994); 2018 Jan 29; 107(3):158-164. PubMed ID: 29382260 [No Abstract] [Full Text] [Related]
47. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview. Corradi V, Gastaldon F, Virzì GM, Caprara C, Martino F, Ronco C. Minerva Med; 2015 Feb 29; 106(1):53-64. PubMed ID: 25300895 [Abstract] [Full Text] [Related]
48. Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease. Lacquaniti A, Chirico V, Lupica R, Buemi A, Loddo S, Caccamo C, Salis P, Bertani T, Buemi M. Peptides; 2013 Nov 29; 49():1-8. PubMed ID: 23973863 [Abstract] [Full Text] [Related]
49. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease. Kim Y, Tao C, Kim H, Oh GY, Ko J, Bae KT. J Am Soc Nephrol; 2022 Aug 29; 33(8):1581-1589. PubMed ID: 35768178 [Abstract] [Full Text] [Related]
51. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation. Shi B, Akbari P, Pourafkari M, Iliuta IA, Guiard E, Quist CF, Song X, Hillier D, Khalili K, Pei Y. Sci Rep; 2019 Jul 29; 9(1):10996. PubMed ID: 31358787 [Abstract] [Full Text] [Related]
55. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease. van Gastel MDA, Edwards ME, Torres VE, Erickson BJ, Gansevoort RT, Kline TL. J Am Soc Nephrol; 2019 Aug 29; 30(8):1514-1522. PubMed ID: 31270136 [Abstract] [Full Text] [Related]
56. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, HALT PKD and CRISP Study Investigators, Harris PC. JCI Insight; 2020 Aug 06; 5(15):. PubMed ID: 32634120 [Abstract] [Full Text] [Related]
57. Recent advances in management of autosomal-dominant polycystic kidney disease. Potts JW, Mousa SA. Am J Health Syst Pharm; 2017 Dec 01; 74(23):1959-1968. PubMed ID: 29167138 [Abstract] [Full Text] [Related]
59. Autosomal dominant polycystic kidney disease: time for a change? Chapman AB. J Am Soc Nephrol; 2007 May 01; 18(5):1399-407. PubMed ID: 17429048 [Abstract] [Full Text] [Related]
60. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Clin J Am Soc Nephrol; 2009 Apr 01; 4(4):838-44. PubMed ID: 19339428 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]